Cerebroxine,
Devincan,
Pervincamine,
Vincamine,
Vincapront,
Vincimax,
vincamine,
1617-90-9,
Devincan,
Pervincamine,
Minorine,
Vincamidol,
Novicet,
Angiopac,
Equipur,
Monorin,
Methyl vincaminate,
Arteriovinca,
Vincasaunier,
(+)-Vincamine,
Anasclerol,
Decincan,
Devinkan,
Tripervan,
Vincadar,
Vincafolina,
Vincapront,
Vinkametrin,
Minorin,
Oxygeron,
Pervone,
Vincafor,
Perval,
Ocu-vinc,
Vincamina [DCIT],
Vincimax,
Vincamine base,
Vincaminum [INN-Latin],
UNII-996XVD0JHT,
Vincamine [INN:BAN:DCF],
Vincachron,
Vincagil,
Vincamin,
Vincapan,
Vinca,
Vinodrel retard,
Vinca-Ecobi,
Vinca-Minor,
HSDB 7150,
Anasclerol (base),
EINECS 216-576-3,
NSC 91998,
996XVD0JHT,
CHEBI:9985,
RXPRRQLKFXBCSJ-GIVPXCGWSA-N,
Alkaloid obtained from Vinca minor,
MFCD00078054,
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-,
14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester,
DSSTox_CID_20134,
DSSTox_RID_79448,
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16.),
DSSTox_GSID_40134,
Cerebroxine,
Vincaminum,
Vincamina,
methyl 14beta-hydroxy-14,15-dihydro-3alpha,16alpha-eburnamenine-14alpha-carboxylate,
Teprosilic Acid,
(3?,14?,16?)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester,
Vincamine (FP),
NCGC00094824-01,
Vincamine (INN),
AK163212,
Prestwick_495,
CAS-1617-90-9,
Cetal retard (TN),
Vincamine, 98%,
Prestwick0_000271,
Prestwick1_000271,
Prestwick2_000271,
Prestwick3_000271,
AC1L25RL,
BSPBio_000142,
GTPL349,
MLS002154249,
SCHEMBL147179,
SPBio_002361,
BPBio1_000158,
CHEMBL1165342,
DTXSID9040134,
BCBcMAP01_000080,
HMS1568H04,
HMS2095H04,
HMS2268C20,
HMS3712H04,
BCP05837,
HY-B1021,
ZINC1069082,
Tox21_111342,
Tox21_301968,
AKOS015896471,
Tox21_111342_1,
API0004593,
CCG-208544,
CS-4536,
DB13374,
EBD2197880,
KS-5179,
SMP1_000314,
Vincamine, analytical reference material,
NCGC00184983-01,
NCGC00184983-03,
NCGC00255542-01,
AC-22625,
AN-49543,
BC681377,
SC-19228,
SMR000112509,
AX8156430,
LS-162175,
ST24050348,
C09251,
D08677,
J10447,
617V909,
I06-1879,
Q-100193,
BRD-K40902647-001-03-7,
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methylester, (3a,14b,16a)-,
methyl (3alpha,14beta,16alpha)-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylate,
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-,methyl ester, (3alpha,14beta,16alpha)-,
methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0?,?.0?,??.0??,??]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate,
methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate,
Vincamine, 98% 1g,
D08UGJ,
C21H26N2O3,
Vincamine [BAN:DCF:INN],
Vincamine, 99% - 1G 1g,
CID15376,
methyl ethyl(hydroxy)[?]carboxylate,
NSC91998,
C21-H26-N2-O3,
ACN-036655,
N016,
D014749,
Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3.alpha.,14.beta.,16.alpha.)-,
(3-alpha,14-beta,16-alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester,